Hinge Health officer plans $3.1M stock sale

An officer of Hinge Health, Inc. has filed a Rule 144 notice to sell 33,000 vested performance-based shares following earlier 10b5-1 sales in 2026.

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) has a notice under Rule 144 from officer James Pursley to sell up to 33,000 shares of common stock through Morgan Stanley Smith Barney LLC. The planned sale has an aggregate market value of $3,131,700 based on the price information provided.

The shares to be sold were acquired upon vesting of performance stock units between April 1, 2023 and March 31, 2025. The notice also lists prior 10b5-1 sales of 33,000 shares each in June and August 2026, reflecting ongoing liquidity transactions by this insider.

Key Figures

Shares to be sold: 33,000 shares Aggregate market value of planned sale: $3,131,700.00 Shares outstanding: 62,468,721 shares +3 more

6 metrics

Shares to be sold 33,000 shares Common stock covered by the Rule 144 notice for James Pursley

Aggregate market value of planned sale $3,131,700.00 Indicated value of 33,000 shares in the Rule 144 securities information section

Shares outstanding 62,468,721 shares Referenced outstanding Hinge Health common shares for Rule 144 context

Past sale on August 21, 2026 33,000 shares for $2,905,663.20 10b5-1 sale of Hinge Health common stock by James Pursley

Past sale on June 22, 2026 33,000 shares for $2,287,253.10 10b5-1 sale of Hinge Health common stock by James Pursley

PSU vesting period April 1, 2023–March 31, 2025 Period during which the performance stock units vested and were acquired

Key Terms

Rule 144, performance stock units, 10b5-1, Form 144

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

performance stock units financial

"The securities to be sold were acquired upon the vesting of performance stock units"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

10b5-1 regulatory

"10b5-1 Sales for JAMES PURSLEY 455 Market Street, Suite 700"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale is disclosed for HNGE in this Form 144?

Officer James Pursley filed a Rule 144 notice to sell up to 33,000 shares of Hinge Health, Inc. common stock through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $3,131,700 for this planned sale.

How were the HNGE shares being sold by James Pursley acquired?

The shares were acquired upon the vesting of performance stock units during the period from April 1, 2023 through March 31, 2025, according to the remarks accompanying the Rule 144 notice.

What prior 2026 sales by James Pursley in HNGE stock are reported?

The notice lists 10b5-1 sales of Hinge Health common stock by James Pursley of 33,000 shares on June 22, 2026 for $2,287,253.10 and 33,000 shares on August 21, 2026 for $2,905,663.20.

What is the aggregate market value of the HNGE shares proposed to be sold?

The 33,000 Hinge Health common shares covered by the notice have an indicated aggregate market value of $3,131,700.00, based on the price information stated in the Rule 144 filing.

How many HNGE shares are outstanding as referenced in the notice?

The Rule 144 notice references 62,468,721 shares of Hinge Health, Inc. common stock outstanding, providing context for the relative size of the 33,000-share planned sale.

Which broker is handling the proposed HNGE sale for James Pursley?

The proposed sale of Hinge Health, Inc. common stock is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as disclosed in the Rule 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/21/2026 - 04:28 PM Accepted by SEC EDGAR 09/21/2026 - 04:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783108
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	JAMES PURSLEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	33000	3131700.00	62468721	09/21/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2023	Performance Stock Units	Issuer			33000	04/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES PURSLEY 455 Market Street, Suite 700 San Francisco CA 94105	Common	08/21/2026	33000	2905663.20
10b5-1 Sales for JAMES PURSLEY 455 Market Street, Suite 700 San Francisco CA 94105	Common	06/22/2026	33000	2287253.10

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of performance stock units during the period of 04/1/2023 through 03/31/2025.
Date of Notice	09/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Pursley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)